Discovery of the S1P2 Antagonist GLPG2938 (1-[2-Ethoxy-6-(trifluoromethyl)-4-pyridyl]-3-[[5-methyl-6-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]pyridazin-3-yl]methyl]urea), a Preclinical Candidate for the Treatment of Idiopathic Pulmonary Fibrosis
Mammoliti, Oscar
;
Palisse, Adeline;
Joannesse, Caroline;
El Bkassiny, Sandy;
Allart, Brigitte; et al,
Journal of Medicinal Chemistry,
2021,
64(9),
6037-6058